Press Room

Press Release / Sep 09, 2011

EFCG Ratifies FDA's Proposed Generic Drug User Fees Act

European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA)

The Board of the European Fine Chemicals Group (EFCG) is delighted to announce that  today it agreed to ratify the proposal of the US Food and Drug Administration (FDA) to put  forward a legislative package, designed with the help of EFCG and US industry  representatives, to deliver into US law a new Generic Drug User Fees Act (GDUFA).   

Read more:   

 

Also in the Press Room